蔡瑞康教授学术经验总结及瘢痕疙瘩辨体—辨病—辨证分析与中药外治研究
|
摘要
目的:总结归纳蔡瑞康教授诊治皮肤病的学术经验。对瘢痕疙瘩(Keloid,K)患者进行辨体、辨病、辨证分析。观察自制中药外治的临床疗效并探讨其作用机制。方法:应用《中医体质分类判定标准》对124例K患者进行中医体质类型研究。对154例K患者的总体及分型后临床资料进行分析。根据《血瘀证诊断标准》等对154例K患者进行血瘀证及兼证类型调查,测定43例K患者血液流变学指标,对5例K患者的不同分型皮损进行超声及皮肤镜检查。采用随机、对照临床试验方法观察自制中药软膏、酊剂外用治疗K疗效。对自制中药作用后的体外培养K成纤维细胞的形态、增殖活性、Ⅰ型胶原蛋白、基质金属蛋白酶1(MMP-1)及血管内皮细胞生长因子(VEGF)的表达及细胞毒性进行检测。结果:①与正常人比较,K患者属湿热质、瘀血质、痰湿质、阴虚质、特禀质、气虚质的百分比增加;男性、女性、17～45岁患者属湿热质的百分比增加;男性、36～45岁患者属瘀血质、痰湿质、阴虚质、特禀质的百分比增加;17～25岁患者属痰湿质、阴虚质的百分比增加;与痤疮患者比较,与痤疮相关K患者属阴虚质的百分比增加(p＜0.05)。②K发病年龄11～30岁占81.17%,有家族史者占25.97%,皮损累及部位依次为胸、背、下颌、四肢、腹腰臀,主要诱因为痤疮(48.70%)、毛囊炎(35.71%)。87.50%胸背下颌多发型K由痤疮诱发,54.90%、23.53%胸部单发型K由毛囊炎、搔抓诱发,四肢多发型、混合型K与瘢痕体质有关,手术居胸外单发型K发病诱因的首位。③99.35%K患者属血瘀证,兼证类型依次为湿热证(61.44%)、气滞证(34.64%)、痰湿证(26.80%)、气虚证(1.31%)。与正常人比较,K患者中切变率30~(-S)、5~(-S)全血粘度值、全血低切还原粘度、红细胞聚集指数增高的病例数增加(p＜0.05)。K皮损内呈缺血或缺动脉血状态,浅部血管数目、分布及形态异常,依皮损分型不同而血流状态及浅部血管表现亦不同。④与积雪苷比较,自制中药软膏外用治疗K12周后,从靶皮损疗效评估、严重程度总评分、分级三种方式判定均差异有统计学意义(p＜0.05)。⑤在一定浓度下,自制中药提取物作用后K成纤维细胞形态发生改变,增殖活性降低,Ⅰ型胶原蛋白表达减低,MMP-1表达增高,VEGF表达呈双向性改变,乳酸脱氢酶(LDH)活性增高。结论:运用中医学及中西医结合理论与方法诊治皮肤病是蔡教授的学术特色。K发生与某些中医体质类型有关。K临床类型不同其发病原因亦不同。K存在着血行瘀滞以及血液流变性异常、皮损处微循环障碍。自制中药软膏治疗K疗效满意,该药从多方面影响着K成纤维细胞的生物性状。
Objective:To summrize the academic experience of prof.Cai Ruikang in diagnosing and treating dermatosis,analyze the patients with keloids by differentiating individual,disease and syndrome,observe the clinical effect of topical therapy of self-made traditional Chinese drug and explore its functional mechanism.Methods:124 patients' body constitution types were researched according to＜TCM Classification Standards of Health＞.154 patients'overall and classified clinical data were analyzed. 154 patients were investigated whether they corresponded to＜Diagnostic Standards for Blood Stasis Syndrome＞or not and about accompanied syndromes.43 patients' hemorheological indexes were detected.5 patients' different types of lesions were evaluated with sonography and demoscopy equipments.Clinical curative effects on keloids with self-made drug were observed by randomized and controlled clinical trial. The drug action on the biological activity of keloid-derived fibroblasts were evaluated with regard to their appearance,proliferation,cytotoxicity and the expressions of typeⅠcollagen,matrix metalloproteinasel(MMP-1)and VEGF.Results:①Compared with the normal group,the percentage of wet-heat,blood-stasis,phlegm-wetness,yin-deficiency, special diathesis and qi-deficiency types increased in the patients with keloids.The percentage of wet-heat type increased in male and female patients,at the 17-45 years of age.The percentage of blood-stasis,phlegm-wetness,yin-deficiency and special diathesis types increased in male patients,at the 36-45 years of age.The percentage of phlegm-wetness and yin-deficiency types increased in the patients at the 17-25 years of age.Compared with the patients with acne,the percentage of yin-deficiency type increased in the patients with acne associated keloids(p＜0.05).②81.17%of the patients had their disease started between the ages of 11 and 30 years,and 25.97%had the positive family history of keloid.Chest,back and submaxilla area were the most common sites for scarring.The major initiating factors of scarring were acne(48.70%) and folliculitis(35.71%).Multiple keloids on the chest,back and submaxilla related to acne(87.50%),solitary keloid on the chest to folliculitis(54.90%)and scratching (23.50%),multiple keloids on the limbs and mixed type to scar physique,solitary keloid on any part except chest to surgery.③99.35%of the patients with blood-stasis syndrome and 61.44%,34.64%,26.80%,1.31%with wet-heat,qi-stagnancy, phlegm-wetness,qi-deficiency syndrome were successively observed.Compared with normal group,the number of the patients being detected four elevating hemorheological indexes increased(p＜0.05).Blood or arterial blood shortage was presented in the lesions of keloids.The number,distribution and shape of superficial blood vessel were abnormal.The status of blood flow and the manifestation of superficial blood vessel were different in the light of different types of lesions.④Compared with asiaticoside group,after having been treated with self-made drug unguent for 12 weeks,the differences determined by general assessment,score and grade on the basis of the severity of target lesion were statistically significant(p＜0.05).⑤Within certain concentration,after the extractant from self-made drug taking action,the fibroblast appearance was altered,the cellular proliferating activity was decreased,the LDH activity was increased and the expression of collagenⅠwas suppressed,the expression of MMP-1 was enhanced while the expression of VEQF was increased or decreased.
Conclusion:Appling TCM and combination of TCM with Western to diagnoses and treatment of dermatosis is prof.Cai's academic characteristics.The occurance of keloid relate to some body constitution types,blood stasis,systemic and topical dysaemia.The onset causes of different keloid types are different.The curative effect of self-made drug unguent is significant in treating keloids.The medicine may influent the biological mechanism of keloid fibroblasts in various aspects.
Objective:To summrize the academic experience of prof.Cai Ruikang in diagnosing and treating dermatosis,analyze the patients with keloids by differentiating individual,disease and syndrome,observe the clinical effect of topical therapy of self-made traditional Chinese drug and explore its functional mechanism.Methods:124 patients' body constitution types were researched according to＜TCM Classification Standards of Health＞.154 patients'overall and classified clinical data were analyzed. 154 patients were investigated whether they corresponded to＜Diagnostic Standards for Blood Stasis Syndrome＞or not and about accompanied syndromes.43 patients' hemorheological indexes were detected.5 patients' different types of lesions were evaluated with sonography and demoscopy equipments.Clinical curative effects on keloids with self-made drug were observed by randomized and controlled clinical trial. The drug action on the biological activity of keloid-derived fibroblasts were evaluated with regard to their appearance,proliferation,cytotoxicity and the expressions of typeⅠcollagen,matrix metalloproteinasel(MMP-1)and VEGF.Results:①Compared with the normal group,the percentage of wet-heat,blood-stasis,phlegm-wetness,yin-deficiency, special diathesis and qi-deficiency types increased in the patients with keloids.The percentage of wet-heat type increased in male and female patients,at the 17-45 years of age.The percentage of blood-stasis,phlegm-wetness,yin-deficiency and special diathesis types increased in male patients,at the 36-45 years of age.The percentage of phlegm-wetness and yin-deficiency types increased in the patients at the 17-25 years of age.Compared with the patients with acne,the percentage of yin-deficiency type increased in the patients with acne associated keloids(p＜0.05).②81.17%of the patients had their disease started between the ages of 11 and 30 years,and 25.97%had the positive family history of keloid.Chest,back and submaxilla area were the most common sites for scarring.The major initiating factors of scarring were acne(48.70%) and folliculitis(35.71%).Multiple keloids on the chest,back and submaxilla related to acne(87.50%),solitary keloid on the chest to folliculitis(54.90%)and scratching (23.50%),multiple keloids on the limbs and mixed type to scar physique,solitary keloid on any part except chest to surgery.③99.35%of the patients with blood-stasis syndrome and 61.44%,34.64%,26.80%,1.31%with wet-heat,qi-stagnancy, phlegm-wetness,qi-deficiency syndrome were successively observed.Compared with normal group,the number of the patients being detected four elevating hemorheological indexes increased(p＜0.05).Blood or arterial blood shortage was presented in the lesions of keloids.The number,distribution and shape of superficial blood vessel were abnormal.The status of blood flow and the manifestation of superficial blood vessel were different in the light of different types of lesions.④Compared with asiaticoside group,after having been treated with self-made drug unguent for 12 weeks,the differences determined by general assessment,score and grade on the basis of the severity of target lesion were statistically significant(p＜0.05).⑤Within certain concentration,after the extractant from self-made drug taking action,the fibroblast appearance was altered,the cellular proliferating activity was decreased,the LDH activity was increased and the expression of collagenⅠwas suppressed,the expression of MMP-1 was enhanced while the expression of VEQF was increased or decreased.
Conclusion:Appling TCM and combination of TCM with Western to diagnoses and treatment of dermatosis is prof.Cai's academic characteristics.The occurance of keloid relate to some body constitution types,blood stasis,systemic and topical dysaemia.The onset causes of different keloid types are different.The curative effect of self-made drug unguent is significant in treating keloids.The medicine may influent the biological mechanism of keloid fibroblasts in various aspects.
引文
[1]Mohel AD.Evaluation of various methods of treating keloid and hypertrophic scars:a 10-years follow up study.Br J Plastic Surg.1992,45:374-378
[2]赵辨.临床皮肤病学.江苏科学技术出版社.2003,第3版:935-938
[3]Bayat A,Arscott G,Ollier WE,et al.Keloid Disease:clinical relevance of single versus multiple site scars.Br J Plastic Surg.2005,58(1):28-37
[4]Cosman B,Crikelair GF,Ju DM,et al.The surgical treatment of keloids.Plast Reconstr Surg.1961,27(6):335-338
[5]Saward Y.Treatment of scars and keloid with a cream containing silicone oil.Br J Plastic Surg.1990,43:683-688
[6]王琦.中医体质学.中国医药科技出版社.1995,第1版:68-90
[7]任小娟,王琦.应用《中医体质分类判定标准》进行个体化健康管理初探.中国中医药信息杂志.2007,14(7):1-2
[8]蒋艳.湿热体质与疾病关系的探讨.中华中医药杂志.2006,21(5):293-294
[9]史洪涛,金东明,史力.“消积排通汤”治疗“蟹足肿”.吉林中医药.1988,(1):5-7
[10]姚玉珍.用活血化瘀法治疗瘢痕疙瘩的临床体会.北京中医杂志.1987,(4):25-26
[11]翟晓翔,罗文辉.中医药治疗瘢痕疙瘩的现状及展望.湖南中医院学报.2004,24(5):62-64
[12]周艳杰,刘光谱.瘢痕的中医药研究现状.光明中医.1998,13(79):21-23
[13]Boyce DE,Ciampolini J,Ruge F,et al.Inflammatory-cell subpopulations in keloids scars.Br J Plast Surg.2001,54(6):511-516
[14]戚辉.痤疮的中西医研究现状.山东医学高等专科学校学报.2007,26(4):304-306
[15]刘叶兰,孙亦农.中医对寻常痤疮病因病机的认识.河南中医.2006,26(4):6-7
[16]王敏,何文彬.瘀血体质的研究进展.光明中医.2007,22(2):48-50
[17]骆斌,王琦.痰湿体质论析.安徽中医院学报.1999,18(5):10-11
[18]钱彦方.肥人痰湿体质学说的形成及现代研究.陕西中医学院学报.1996,19(3):5-7
[19]李小兵,方永奇,黄可儿.痰瘀证型的临床分析.辽宁中医杂志.2000,27(2):53-55
[20]任小娟,王琦.浅谈阴虚体质与阴虚证的区别.中医研究.2007,20(10):1-2
[21]周唯.慢性难治病阴虚复合证探讨.中医药学报.2008,36(5):7-9
[22]Ramakrishnan KM,Thomas KP,Sundararajan CR.Study of 1,000 patients with keloids in South India.Plast Reconstr Surg.1974,53(3):276-280
[23]Sharquie KE,Al-Dhalimi MA.Keloid in Iraqipatients:a clinicohistopathologic study.Dermatol Surg.2003,29(8):847-851
[24]陈阳,高建华,刘晓军,等.瘢痕疙瘩中国家系的发病特点研究.中国美容医学.2006,15(1):6-10
[25]舒春梅,何春涤,刘勇,等.410例辽籍汉族瘢痕疙瘩临床流行病学分析.中国麻风皮肤病杂志.2007,23(7):592-594
[26]Ford LC,King DF,Lagasse LD,et al.Increased androgen binding in keloids:a preliminary communication.J Dermatol Surg Oncol.1983,9(7):545-547
[27]Schierle HP,Scholz D,Lemperle G.Elevated levels of testosterone receptors in keloid tissue:an experimental investigation.Plast Reconstr Surg.1997,100(2):390-396
[28]Ohtsuru A,Yoshimoto H,Ishihara H,et al.Insulin-like growth factor-Ⅰ(IGF-Ⅰ)/IGF-Ⅰ receptor axis and increased invasion activity of fibroblasts in keloid.Endocr J.2000,47(Suppl):41-44
[29]Ketchum LD,Cohen IK,Masters FW.Hypertrophic scars and keloids.A collective review.Plast Reconstr Surg.1974,53(2):140-154
[30]靳瑾,高建华.瘢痕疙瘩发病机制的研究动态.中围组织工程研究与临床康复.2007,11(10):1953-1956,1973
[31]Fong EP,Bay BH.Keloids-the sebum hypothesis revisited.Med Hypotheses.2002,58(4):264-269
[32]姜笃银,陈璧,徐明达,等.病理性瘢痕组织中角朊细胞的免疫诱导作用.第四军医大学学报.2001,22(1):40-43
[33]姜笃银,付小兵,陈伟,等.瘢痕疙瘩中皮肤附件结构破坏与瘢痕增生的关系.中国修复重建外科杂志.2005,19(1):15-19
[34]Louw L.The keloid phenomenon:progress toward a solution.Clin Anat.2007,20(1):3-14
[35]Layton AM,Henderson CA,Cunliffe WJ.A clinical evaluation of ache scarring and its incidence.Clin Exp Dermatol.1994,19(4):303-308
[36]吴艳,毛越苹,郑捷,等.寻常痤疮严重程度和瘢痕相关因素分析.临床皮肤科杂志.2004,33(7):395-397
[37]刘文阁,李素娟.瘢痕预防治疗学.北京学苑出版社.2000,第1版:26
[38]中国中西医结合研究会活血化瘀研究专业委员会.血瘀证诊断标准.中国中西医结合杂志.1987,7(3):129
[39]王阶,陈可冀,翁维良,等.血瘀证诊断标准的研究.中国中西医结合杂志.1988,8(10):585-587,589
[40]鲍卫汉,王传民,朱洪荫,等.瘢痕疙瘩不同部位组织形态学研究.中华整形烧伤外科杂志.1995,11(5):368-370
[41]高永波,胡颖,刘国庆,等.瘢痕疙瘩的超声检查.吉林医学院学报.1995,15(3):48-49
[42]贾数蓉,丛林,李世荣,等.B 超对皮肤增生瘢痕检测的评价.第三军医大学学报.1998,20(12):543-544
[43]王殿俊.血瘀证临床及实验研究进展.微循环技术杂志.1995,(1):34-38
[44]吴承玉.血瘀证的研究发展脉络.南京中医药大学学报.2004,20(3):133-136
[45]张静,陈克进,田金洲.浅述血瘀证的形成与发展.湖北中医学院学报.2005,7(4):39-40
[46]时晶,田金洲,王永炎,等.血瘀证的生物学基础.中华中医药杂志.2006,21(6):363-364
[47]王阶,姚魁武.血瘀证诊断标准研究述要及思考.中国中医药信息杂志.2004,11(1):17-19
[48]Hosoda G,Holloway GA,Heimbach DM.Laser Doppler flowmety for the early detection of hypetrophic burn scars.J Burn Care Rehabil.1986,7(6):496-497
[49]Timar-Banu O,Beauregard H,Tousignant J,et al.Development of noninvasive and quantitative methodologies for assessment of cgronic ulcers and scars in humans.Wound Repair Regen.2001,9(2):123-132
[50]李小静,孟刚,宁金龙,等.免疫组化法对不同类型瘢痕微血管的定量研究.实用美容整形外科杂志.2000,11(4):207-209
[51]王臻,郭树忠,张琳西,等.增生性瘢痕组织中血管形成的形态学.第四军医大学学报.2001,17(1):22
[52]Beer TW,Baldwin HC,Goddard JR,et al.Angiogenesis in pathological and surgical scars.Hum Pathol.1998,29(11):1273-1278
[53]Kischer CW.The microvessels in hypertrophic scars,keloids and related lesions:a review.J Submicrosc Cytol Pathol.1992,24:281-296
[54]李高峰,罗成群,刘浔阳,等.瘢痕内微循环的变化.中华医学美学美容杂志.2005,11(4):223-226
[55]Sloan DF,Brown RD,Wells CH,et al.Tissue gases in human hypertrophic scars. Plast Reconstr Surg.1978,61(3):431-436
[56]秦泽莲.增生性瘢痕异常增生的启动因素.中华整形外科杂志.2003,19(2):135-137
[57]Ehrlich HP,Kelley SP.Hypertrophic scars:an interruption in the remodeling of repair-a laser Doppler blood flow study.Plast Reconstr Surg.1992,90(6):993
[58]毛运春,唐红梅,庄强,等.前胸部瘢痕疙瘩微血管的形态和分布.微循环学杂志.2007,17(3):24-26
[59]姜笃银,付小兵,陈伟,等.血管内皮细胞及其受体过表达与瘢痕疙瘩侵袭性生长.中华整形外科杂志.2004,20(3):128-131
[60]Tanaka A,Hatoko M,Tada H,et al.Expression of p53 family in scars.J dermatol Sci.2004,34(1):17-24
[61]林召,骆芦娟,汪凡军.血液流变学结果分析.现代医药卫生.2003,19(7):913-914
[62]孟如松,蔡瑞康,赵广,等.多光谱皮肤图像分析管理系统的研究与应用.解放军医学杂志.1999,24(12):469-471
[63]孟如松,赵广.皮肤镜图像分析技术的基础与临床应用.临床皮肤科杂志.2008,37(4):264-266
[64]李荟元.瘢痕的药物治疗进展.中国临床康复.2002,6(8):1090-1092
[65]王焱,张国成.瘢痕疙瘩的临床治疗进展.国外医学皮肤性病分册.2005,31(2):75-77
[66]闫宏山,蔡景龙.瘢痕的中医药治疗及其研究现状.中国美容医学.2006,15(9):1093-1095
[67]赵亮,方方,王焱,等.手术后放疗加口服积雪甙治疗瘢痕疙瘩的临床研究.中华皮肤科杂志.2003,36(6):342-344
[68]雷田香,彭延古,徐爱良.中药全蝎的研究进展.湖南中医学院学报.2006,26(4):60-61
[69]张荒生,王进军.中药全蝎的药理研究进展.中国中医急症.2007,16(2):224-226
[70]唐炳兰.中药重搂的研究进展.右江民族医学院.2006,(6):1062-1063
[71]卢汝梅,杨长水,苏醒,等.重楼属药用植物的最新研究进展.新医学学刊.2008,5(7):083-1084
[72]付新芳,刘晓红.丹参的药理作用与临床应用研究进展.中国药业.2006,15(1):76-77
[73]袁恒杰.丹参素药理作用研究新进展.中国医院药学杂志.2006,26(5):604-606
[74]杨卫.丹参注射治疗瘢痕疙瘩40例.中医杂志.2002,43(6):448
[75]张盘根.复方丹参注射液治疗瘢痕疙瘩34例.新中医.2003,35(8):62
[76]王芊,曹德君.丹参对培养的人瘢痕成纤维细胞生长和胶原形成的影响.中国临床药学杂志.2002,11(1):46-48
[77]商庆新,张涤生,关文祥,等.丹参和川芎嗪对瘢痕成纤维细胞 DNA 含量及细胞周期进程的影响.中国修复重建外科杂志.1998,12(6):325-327
[78]左强,张培华,罗少军,等.丹参酮Ⅱ A 对瘢痕成纤维细胞增殖及凋亡的影响.广东医学.2004,25(6):636-637
[79]郑学毅,唐培昀,梁惠仪.丹参对瘢痕疙瘩成纤维细胞基质金属蛋白酶-1的作用.中华医学美容杂志.2007,13(1):29-31
[80]崔锐,周金云.乳香化学和药理的研究进展.中国药学杂志.2006,38(6):407-410
[81]郭辉,张玲.乳香中化学成分及药理作用的研究进展.食品与药品.2007,9(5):50-52
[82]陈梅花,王慧春,朱艳,等.贝母的药理研究.安徽农学通报.2007,13(1):103-105
[83]于辉,李春香,宫凌涛,等.甘草的药理作用概述.现代生物医学进展.2006,6(4):77-79
[84]赵敏珍,胡德玉,王学恩,等.甘草甜素、甘草次酸与柴胡皂甙等防治大白鼠实验性肺纤维化的作用.药学学报.1983,(5):325
[85]王吉耀,刘继田,胡美云,等.甘草酸对成纤维细胞Ⅰ、Ⅲ型前胶原 mRNA 表达的抑制作用.肝脏.1996,(1):81
[86]苏毅鹏,匡瑞霞,鲍国春,等.川芎嗪等多种中药制剂对兔耳增生性瘢痕作用对比研究.齐鲁医学杂志.2004,19(8):322-324
[87]郭海霞,吴延芳.川芎嗪和甘利欣对瘢痕成纤维细胞增殖和Ⅰ型、Ⅲ型前胶原mRNA 的表达.中国中医结合皮肤性病学杂志.2002,1(1):27-30
[88]宋震坤,宋建良.中医药治疗瘢痕之研究现状.中华整形外科杂志.2003,19(4):297-299
[89]黄辉,李宇明,陈东明,等.消瘢醑对瘢痕疙瘩成纤维细胞Ⅰ、Ⅲ型胶原蛋白的影响.中国微创外科杂志.2003,3(3):249-251
[90]李宇明,李生,李建宁,等.消瘢醑对瘢痕疙瘩成纤维细胞增殖的影响.中国微创外科杂志.2004,4(6):531-532
[91]董永洪,李卫华,刘洪琪,等.复方消疤口服液抑制增生性瘢痕成纤维细胞的实验研究.中华烧伤杂志.2003,19(增刊):47-48
[92]张颖,王芳,李萍,等.回阳生肌膏提取物对人慢性皮肤溃疡创缘成纤维细胞体外促增殖研究.中国中西医结合外科杂志.2006,12(4):391-394
[93]司徒镇强,吴军正.细胞培养.世界图书出版社公司.2001,第1版:6-85
[94]Aggeler J,Frisch SM,Werb I.Changes in cell shape correlate whit collagenase gene expression in rabbit synovial fibroblasts.J Cell Biol.1984,98(5):1662-1671
[95]潘敏,骆丹.基质金属蛋白酶与皮肤病相关性.国际皮肤性病学杂志.2007,33(1):53-55
[96]陈红清,徐文严.皮肤中的基质金属蛋白酶.国外医学皮肤性病分册.1999,25(2):104-106
[97]Arakawa M,Hatamochi A,Mori Y,et al.Reduced collagenase gene expression in fibroblasts from hypertrophic scar tissue.Br J Dermatol.1996,134:863-868
[98]Uchida G,Yoshimura K,Kitano Y,et al.Tretinoin reverses up-regulation of matrix metalloproteinase-13 in human keloid-derived fibroblasts.Exp Dermatol,2003,12(Suppl 2):35-42
[99]陆兴安,许明,沈国良,等.病理性瘢痕组织中 TGF-β1及 MMP-1的表达.江苏医药.2005,31(12):901-903
[100]郭丽丽,刘林嶓,陈言汤.MMP-1、TIMP-1及 PDGF 在病理性瘢痕中的表达.中国美容整形外科杂志.2006,17(5):340-342
[101]李万同,柳大烈,刘晓燕,等.汉防己甲素对增生性瘢痕成纤维细胞基质金属蛋白酶Ⅰ合成的影响.中国临床康复.2005,9(10):106-107
[102]张涛,荣新洲,杨荣华,等.积雪草甙对增生性瘢痕转化生长因子-β mRNA 及基质金属蛋白酶类表达的影响.南方医科大学学报.2006,26(1):67-70
[103]Gira AK,Brown LF,Washington CT,et al.Keloid demonstrate high-level epidermal expression of vascular endothelial growth factor.J Am Acad Dermatol.2004,50(6):650-653
[104]姜笃银,徐明达,陈璧,等.瘢痕疙瘩组织血管生长因子及其受体表达的意义.第四军医大学学报.1998,19(4):470-471
[105]李军辉,邢新,欧阳天祥,等.异常瘢痕中血管内皮细胞生长因子和增殖性核抗原的表达.现代康复.2000,4(9):1358-1359
[106]沈锐,利天增,祁少海,等.靶向血管治疗增生性瘢痕的实验研究.中华整形外科杂志.2003,19(4):254-256
1.李荟元,刘建波,兰海.建立增生性瘢痕动物实验模型.第四军医大学学报,1998,19(6):655-657
2.刘流,赵德萍,余梅,等.丹参对瘢痕成纤维细胞生物学行为的影响.昆明医学院学报,2006,(3):41-45
3.雷水生,唐省三,张瑞莲,等.川芎嗪对瘢痕成纤维细胞形态和增殖抑制的影响.齐齐哈尔医学院学报,2003,24(6):606-607
4.陈明春,黄茂芳.积雪草甙和苦参碱对皮肤瘢痕成纤维细胞生长及胶原合成影响的研究.中国中西医结合皮肤性病学杂志,2006,5(1):11～14
5.李万同,罗力生,柳大烈.汉防己甲素对增生性瘢痕成纤维细胞增殖和活力的影响.现代康复,2000,4(1):66-67
6.姚恒,李世荣,刘剑毅.三七总甙对人增生性瘢痕成纤维细胞 TGF-β_1和细胞周期的作用.中国实用美容整形外科杂志,2005,16(4):243-245
7.谢举临,利天增,祁少海,等.积雪草甙对体外培养的成纤维细胞的作用.中山医科大学学报,2001,22(1):41-43,47
8.汤苏阳,黄高升,蔡宝仁.苦参碱对人增生性瘢痕成纤维细胞超微结构的影响.中国美容医学,2001,10(2):100-101
9.任丽虹,郝立君,段国新,等.五倍子、蜈蚣对瘢痕疙瘩成纤维细胞增殖和胶原合成的影响.实用美容整形外科杂志,2003,14(6):324-327
10.刘流,赵德萍,余梅,等.丹参对兔耳瘢痕模型作用的实验研究.华西口腔医学杂志,2006,24(5):476-477
11.刘德伍,李国辉,刘德明,等.粉防己碱对瘢痕成纤维细胞的生物学作用.江西医学院学报,2001,41(3):4-6
12.王芊,曹德君.丹参对培养的人瘢痕成纤维细胞生长和胶原形成的影响.中国临床药学杂志,2002,11(1):46-48
13.左强,张培华,罗少军,等.丹参酮Ⅱ A 对瘢痕成纤维细胞增殖及凋亡的影响.广东医学,2004,25(6):636-637
14.郭海霞,吴延芳.川芎嗪和甘利欣对瘢痕成纤维细胞增殖和Ⅰ、Ⅲ型前胶原基因表达的影响.中国中西医结合皮肤性病学杂志,2002,1(1):27-30
15.刘剑毅,李世荣,纪淑兴,等.三七总甙对人增生性瘢痕成纤维细胞及胶原合成的作用.第三军医大学学报,2003,17(9):1562-1563
16.沈丹蓓,夏隆庆,鞠强,等.五倍子等对体外培养的人皮肤瘢痕组织成纤维细胞生长的影响.中华皮肤科杂志,2002,35(4):299-301
17.沈雁,李叶杨,唐毅,等.鸦胆子粗提物抑制人成纤维细胞的实验研究.广东药学院学报,2001,(17)2:109-111
18.雷晓红,曹志明,黄恩.丹参对增生性瘢痕成纤维细胞胶原合成的影响及其机制研究.中国临床康复,8(32):7231～7233
19.汤苏阳,蔡宝仁,黄高升,等.苦参碱对人增生性瘢痕成纤维细胞周期和 PCNA 表达的影响.现代康复,2001,5(9):48-49
20.商庆新,张涤生,关文祥,等.丹参和川芎嗪对瘢痕成纤维细胞生长的体外抑制实验.中国修复重建外科杂志,1998,12(6):321-323
21.李宇明,李生,李建宁,等.消瘢醑对瘢痕疙瘩成纤维细胞增殖的影响.中国微创外科杂志,2004,4(6):531-532
22.王瑞国,王锦菊,余祥彬,等.积雪草甙对成纤维细胞 DNA 合成与胶原蛋白合成的影响.福建中医学院学报,2001,11(2):41-42
23.商庆新,张涤生,关文祥,等.丹参和川芎嗪对瘢痕成纤维细胞 DNA 含量及细胞周期进程的影响.中国修复重建外科杂志,1998,12(6):325-327
24.曹治东,石崇荣,黄崇本,等.汉防己甲素对增生性瘢痕成纤维细胞增殖的影响.重庆医科大学学报,2005,30(2):203-205
25.张培华,罗少军,梁杰,等.芦荟大黄素对增生性瘢痕成纤维细胞凋亡的量效影响.中国临床康复,2005,9(30):152-154
26.钟晓春.粉防己碱促进增生性瘢痕成纤维细胞凋亡的实验研究.杭州师范学院学报,2005,4(6):426-427
27.雷晓红,曹志明,黄恩.丹参对增生性瘢痕成纤维细胞 Survivin 表达的影响及意义.中国临床康复,2004,8(35):8042-8044
28.姜会庆,哈团柱,韦多,等.丹参素对成纤维细胞生物学作用机制的研究,中华烧伤杂志,2001,17(1):36-38
29.雷晓红,曹志明,黄恩.丹参对增生性瘢痕成纤维细胞生长的影响.中国临床康复,2004,8(29):6440-6441
30.兰海,王臻,张琳西,等.川芎嗪抑制瘢痕成纤维细胞增殖及胶原的合成.第四军医大学学报,1999,20(11):964-965
31.刘德伍,李国辉,刘德明.粉防己碱对瘢痕成纤维细胞活性功能的影响.中华医学美容杂志,2002,8(4):201-204
32.吴志远,罗少军,汤少明,等.丹参酮ⅡA 对兔耳增生性瘢痕组织形成的影响.广东医学院学报,2002,20(4):255,259
33.张涛,荣新洲,杨荣华,等.积雪草甙对增生性瘢痕转化生长因子-β mRNA 及基质金属蛋白酶类表达的影响.南方医科大学学报,2006,26(1):67-70
34.李万同,柳大烈,罗力生.汉防己甲素对成纤维细胞Ⅰ型胶原蛋白合成的影响.实用美容整形外科杂志,2002,13(6):327-329
35.黄辉,李宇明,陈东明,等.消瘢醑对瘢痕疙瘩成纤维细胞Ⅰ、Ⅲ型胶原蛋白的影响.中国微创外科杂志,2003,3(3):249-251
36.李万同,柳大烈,刘晓燕,等.汉防己甲素对增生性瘢痕成纤维细胞基质金属蛋白酶Ⅰ合成的影响.中国临床康复,2005,9(10):106-107
37.王益民.丹参抑制瘢痕形成的机制研究.山西医科大学学报,2001,32(4):302-303
38.潘姝,利天增,李叶扬,等.积雪草甙对增生性瘢痕成纤维细胞增殖与 Smad7蛋白的影响.第三军医大学学报,2005,27(1):49-52
39.刘德伍,李国辉,邹萍,等.粉防己碱对 PDGF、TGF-β诱导瘢痕成纤维细胞增殖与胶原合成的抑制作用.中国药理与临床,2004,20(4):10～11
40.苏毅鹏,匡瑞霞,鲍国春,等.川芎嗪等多种中药制剂对兔耳增生性瘢痕作用的对比研究.齐鲁医学杂志,2004,19(4):322-324
41.陈远征,刘达恩,王润秀,等.防治瘢痕外用复方中药对兔耳增生性瘢痕微血管及血流的影响.中国临床康复,2006,10(7):43-44
[2]赵辨.临床皮肤病学.江苏科学技术出版社.2003,第3版:935-938
[3]Bayat A,Arscott G,Ollier WE,et al.Keloid Disease:clinical relevance of single versus multiple site scars.Br J Plastic Surg.2005,58(1):28-37
[4]Cosman B,Crikelair GF,Ju DM,et al.The surgical treatment of keloids.Plast Reconstr Surg.1961,27(6):335-338
[5]Saward Y.Treatment of scars and keloid with a cream containing silicone oil.Br J Plastic Surg.1990,43:683-688
[6]王琦.中医体质学.中国医药科技出版社.1995,第1版:68-90
[7]任小娟,王琦.应用《中医体质分类判定标准》进行个体化健康管理初探.中国中医药信息杂志.2007,14(7):1-2
[8]蒋艳.湿热体质与疾病关系的探讨.中华中医药杂志.2006,21(5):293-294
[9]史洪涛,金东明,史力.“消积排通汤”治疗“蟹足肿”.吉林中医药.1988,(1):5-7
[10]姚玉珍.用活血化瘀法治疗瘢痕疙瘩的临床体会.北京中医杂志.1987,(4):25-26
[11]翟晓翔,罗文辉.中医药治疗瘢痕疙瘩的现状及展望.湖南中医院学报.2004,24(5):62-64
[12]周艳杰,刘光谱.瘢痕的中医药研究现状.光明中医.1998,13(79):21-23
[13]Boyce DE,Ciampolini J,Ruge F,et al.Inflammatory-cell subpopulations in keloids scars.Br J Plast Surg.2001,54(6):511-516
[14]戚辉.痤疮的中西医研究现状.山东医学高等专科学校学报.2007,26(4):304-306
[15]刘叶兰,孙亦农.中医对寻常痤疮病因病机的认识.河南中医.2006,26(4):6-7
[16]王敏,何文彬.瘀血体质的研究进展.光明中医.2007,22(2):48-50
[17]骆斌,王琦.痰湿体质论析.安徽中医院学报.1999,18(5):10-11
[18]钱彦方.肥人痰湿体质学说的形成及现代研究.陕西中医学院学报.1996,19(3):5-7
[19]李小兵,方永奇,黄可儿.痰瘀证型的临床分析.辽宁中医杂志.2000,27(2):53-55
[20]任小娟,王琦.浅谈阴虚体质与阴虚证的区别.中医研究.2007,20(10):1-2
[21]周唯.慢性难治病阴虚复合证探讨.中医药学报.2008,36(5):7-9
[22]Ramakrishnan KM,Thomas KP,Sundararajan CR.Study of 1,000 patients with keloids in South India.Plast Reconstr Surg.1974,53(3):276-280
[23]Sharquie KE,Al-Dhalimi MA.Keloid in Iraqipatients:a clinicohistopathologic study.Dermatol Surg.2003,29(8):847-851
[24]陈阳,高建华,刘晓军,等.瘢痕疙瘩中国家系的发病特点研究.中国美容医学.2006,15(1):6-10
[25]舒春梅,何春涤,刘勇,等.410例辽籍汉族瘢痕疙瘩临床流行病学分析.中国麻风皮肤病杂志.2007,23(7):592-594
[26]Ford LC,King DF,Lagasse LD,et al.Increased androgen binding in keloids:a preliminary communication.J Dermatol Surg Oncol.1983,9(7):545-547
[27]Schierle HP,Scholz D,Lemperle G.Elevated levels of testosterone receptors in keloid tissue:an experimental investigation.Plast Reconstr Surg.1997,100(2):390-396
[28]Ohtsuru A,Yoshimoto H,Ishihara H,et al.Insulin-like growth factor-Ⅰ(IGF-Ⅰ)/IGF-Ⅰ receptor axis and increased invasion activity of fibroblasts in keloid.Endocr J.2000,47(Suppl):41-44
[29]Ketchum LD,Cohen IK,Masters FW.Hypertrophic scars and keloids.A collective review.Plast Reconstr Surg.1974,53(2):140-154
[30]靳瑾,高建华.瘢痕疙瘩发病机制的研究动态.中围组织工程研究与临床康复.2007,11(10):1953-1956,1973
[31]Fong EP,Bay BH.Keloids-the sebum hypothesis revisited.Med Hypotheses.2002,58(4):264-269
[32]姜笃银,陈璧,徐明达,等.病理性瘢痕组织中角朊细胞的免疫诱导作用.第四军医大学学报.2001,22(1):40-43
[33]姜笃银,付小兵,陈伟,等.瘢痕疙瘩中皮肤附件结构破坏与瘢痕增生的关系.中国修复重建外科杂志.2005,19(1):15-19
[34]Louw L.The keloid phenomenon:progress toward a solution.Clin Anat.2007,20(1):3-14
[35]Layton AM,Henderson CA,Cunliffe WJ.A clinical evaluation of ache scarring and its incidence.Clin Exp Dermatol.1994,19(4):303-308
[36]吴艳,毛越苹,郑捷,等.寻常痤疮严重程度和瘢痕相关因素分析.临床皮肤科杂志.2004,33(7):395-397
[37]刘文阁,李素娟.瘢痕预防治疗学.北京学苑出版社.2000,第1版:26
[38]中国中西医结合研究会活血化瘀研究专业委员会.血瘀证诊断标准.中国中西医结合杂志.1987,7(3):129
[39]王阶,陈可冀,翁维良,等.血瘀证诊断标准的研究.中国中西医结合杂志.1988,8(10):585-587,589
[40]鲍卫汉,王传民,朱洪荫,等.瘢痕疙瘩不同部位组织形态学研究.中华整形烧伤外科杂志.1995,11(5):368-370
[41]高永波,胡颖,刘国庆,等.瘢痕疙瘩的超声检查.吉林医学院学报.1995,15(3):48-49
[42]贾数蓉,丛林,李世荣,等.B 超对皮肤增生瘢痕检测的评价.第三军医大学学报.1998,20(12):543-544
[43]王殿俊.血瘀证临床及实验研究进展.微循环技术杂志.1995,(1):34-38
[44]吴承玉.血瘀证的研究发展脉络.南京中医药大学学报.2004,20(3):133-136
[45]张静,陈克进,田金洲.浅述血瘀证的形成与发展.湖北中医学院学报.2005,7(4):39-40
[46]时晶,田金洲,王永炎,等.血瘀证的生物学基础.中华中医药杂志.2006,21(6):363-364
[47]王阶,姚魁武.血瘀证诊断标准研究述要及思考.中国中医药信息杂志.2004,11(1):17-19
[48]Hosoda G,Holloway GA,Heimbach DM.Laser Doppler flowmety for the early detection of hypetrophic burn scars.J Burn Care Rehabil.1986,7(6):496-497
[49]Timar-Banu O,Beauregard H,Tousignant J,et al.Development of noninvasive and quantitative methodologies for assessment of cgronic ulcers and scars in humans.Wound Repair Regen.2001,9(2):123-132
[50]李小静,孟刚,宁金龙,等.免疫组化法对不同类型瘢痕微血管的定量研究.实用美容整形外科杂志.2000,11(4):207-209
[51]王臻,郭树忠,张琳西,等.增生性瘢痕组织中血管形成的形态学.第四军医大学学报.2001,17(1):22
[52]Beer TW,Baldwin HC,Goddard JR,et al.Angiogenesis in pathological and surgical scars.Hum Pathol.1998,29(11):1273-1278
[53]Kischer CW.The microvessels in hypertrophic scars,keloids and related lesions:a review.J Submicrosc Cytol Pathol.1992,24:281-296
[54]李高峰,罗成群,刘浔阳,等.瘢痕内微循环的变化.中华医学美学美容杂志.2005,11(4):223-226
[55]Sloan DF,Brown RD,Wells CH,et al.Tissue gases in human hypertrophic scars. Plast Reconstr Surg.1978,61(3):431-436
[56]秦泽莲.增生性瘢痕异常增生的启动因素.中华整形外科杂志.2003,19(2):135-137
[57]Ehrlich HP,Kelley SP.Hypertrophic scars:an interruption in the remodeling of repair-a laser Doppler blood flow study.Plast Reconstr Surg.1992,90(6):993
[58]毛运春,唐红梅,庄强,等.前胸部瘢痕疙瘩微血管的形态和分布.微循环学杂志.2007,17(3):24-26
[59]姜笃银,付小兵,陈伟,等.血管内皮细胞及其受体过表达与瘢痕疙瘩侵袭性生长.中华整形外科杂志.2004,20(3):128-131
[60]Tanaka A,Hatoko M,Tada H,et al.Expression of p53 family in scars.J dermatol Sci.2004,34(1):17-24
[61]林召,骆芦娟,汪凡军.血液流变学结果分析.现代医药卫生.2003,19(7):913-914
[62]孟如松,蔡瑞康,赵广,等.多光谱皮肤图像分析管理系统的研究与应用.解放军医学杂志.1999,24(12):469-471
[63]孟如松,赵广.皮肤镜图像分析技术的基础与临床应用.临床皮肤科杂志.2008,37(4):264-266
[64]李荟元.瘢痕的药物治疗进展.中国临床康复.2002,6(8):1090-1092
[65]王焱,张国成.瘢痕疙瘩的临床治疗进展.国外医学皮肤性病分册.2005,31(2):75-77
[66]闫宏山,蔡景龙.瘢痕的中医药治疗及其研究现状.中国美容医学.2006,15(9):1093-1095
[67]赵亮,方方,王焱,等.手术后放疗加口服积雪甙治疗瘢痕疙瘩的临床研究.中华皮肤科杂志.2003,36(6):342-344
[68]雷田香,彭延古,徐爱良.中药全蝎的研究进展.湖南中医学院学报.2006,26(4):60-61
[69]张荒生,王进军.中药全蝎的药理研究进展.中国中医急症.2007,16(2):224-226
[70]唐炳兰.中药重搂的研究进展.右江民族医学院.2006,(6):1062-1063
[71]卢汝梅,杨长水,苏醒,等.重楼属药用植物的最新研究进展.新医学学刊.2008,5(7):083-1084
[72]付新芳,刘晓红.丹参的药理作用与临床应用研究进展.中国药业.2006,15(1):76-77
[73]袁恒杰.丹参素药理作用研究新进展.中国医院药学杂志.2006,26(5):604-606
[74]杨卫.丹参注射治疗瘢痕疙瘩40例.中医杂志.2002,43(6):448
[75]张盘根.复方丹参注射液治疗瘢痕疙瘩34例.新中医.2003,35(8):62
[76]王芊,曹德君.丹参对培养的人瘢痕成纤维细胞生长和胶原形成的影响.中国临床药学杂志.2002,11(1):46-48
[77]商庆新,张涤生,关文祥,等.丹参和川芎嗪对瘢痕成纤维细胞 DNA 含量及细胞周期进程的影响.中国修复重建外科杂志.1998,12(6):325-327
[78]左强,张培华,罗少军,等.丹参酮Ⅱ A 对瘢痕成纤维细胞增殖及凋亡的影响.广东医学.2004,25(6):636-637
[79]郑学毅,唐培昀,梁惠仪.丹参对瘢痕疙瘩成纤维细胞基质金属蛋白酶-1的作用.中华医学美容杂志.2007,13(1):29-31
[80]崔锐,周金云.乳香化学和药理的研究进展.中国药学杂志.2006,38(6):407-410
[81]郭辉,张玲.乳香中化学成分及药理作用的研究进展.食品与药品.2007,9(5):50-52
[82]陈梅花,王慧春,朱艳,等.贝母的药理研究.安徽农学通报.2007,13(1):103-105
[83]于辉,李春香,宫凌涛,等.甘草的药理作用概述.现代生物医学进展.2006,6(4):77-79
[84]赵敏珍,胡德玉,王学恩,等.甘草甜素、甘草次酸与柴胡皂甙等防治大白鼠实验性肺纤维化的作用.药学学报.1983,(5):325
[85]王吉耀,刘继田,胡美云,等.甘草酸对成纤维细胞Ⅰ、Ⅲ型前胶原 mRNA 表达的抑制作用.肝脏.1996,(1):81
[86]苏毅鹏,匡瑞霞,鲍国春,等.川芎嗪等多种中药制剂对兔耳增生性瘢痕作用对比研究.齐鲁医学杂志.2004,19(8):322-324
[87]郭海霞,吴延芳.川芎嗪和甘利欣对瘢痕成纤维细胞增殖和Ⅰ型、Ⅲ型前胶原mRNA 的表达.中国中医结合皮肤性病学杂志.2002,1(1):27-30
[88]宋震坤,宋建良.中医药治疗瘢痕之研究现状.中华整形外科杂志.2003,19(4):297-299
[89]黄辉,李宇明,陈东明,等.消瘢醑对瘢痕疙瘩成纤维细胞Ⅰ、Ⅲ型胶原蛋白的影响.中国微创外科杂志.2003,3(3):249-251
[90]李宇明,李生,李建宁,等.消瘢醑对瘢痕疙瘩成纤维细胞增殖的影响.中国微创外科杂志.2004,4(6):531-532
[91]董永洪,李卫华,刘洪琪,等.复方消疤口服液抑制增生性瘢痕成纤维细胞的实验研究.中华烧伤杂志.2003,19(增刊):47-48
[92]张颖,王芳,李萍,等.回阳生肌膏提取物对人慢性皮肤溃疡创缘成纤维细胞体外促增殖研究.中国中西医结合外科杂志.2006,12(4):391-394
[93]司徒镇强,吴军正.细胞培养.世界图书出版社公司.2001,第1版:6-85
[94]Aggeler J,Frisch SM,Werb I.Changes in cell shape correlate whit collagenase gene expression in rabbit synovial fibroblasts.J Cell Biol.1984,98(5):1662-1671
[95]潘敏,骆丹.基质金属蛋白酶与皮肤病相关性.国际皮肤性病学杂志.2007,33(1):53-55
[96]陈红清,徐文严.皮肤中的基质金属蛋白酶.国外医学皮肤性病分册.1999,25(2):104-106
[97]Arakawa M,Hatamochi A,Mori Y,et al.Reduced collagenase gene expression in fibroblasts from hypertrophic scar tissue.Br J Dermatol.1996,134:863-868
[98]Uchida G,Yoshimura K,Kitano Y,et al.Tretinoin reverses up-regulation of matrix metalloproteinase-13 in human keloid-derived fibroblasts.Exp Dermatol,2003,12(Suppl 2):35-42
[99]陆兴安,许明,沈国良,等.病理性瘢痕组织中 TGF-β1及 MMP-1的表达.江苏医药.2005,31(12):901-903
[100]郭丽丽,刘林嶓,陈言汤.MMP-1、TIMP-1及 PDGF 在病理性瘢痕中的表达.中国美容整形外科杂志.2006,17(5):340-342
[101]李万同,柳大烈,刘晓燕,等.汉防己甲素对增生性瘢痕成纤维细胞基质金属蛋白酶Ⅰ合成的影响.中国临床康复.2005,9(10):106-107
[102]张涛,荣新洲,杨荣华,等.积雪草甙对增生性瘢痕转化生长因子-β mRNA 及基质金属蛋白酶类表达的影响.南方医科大学学报.2006,26(1):67-70
[103]Gira AK,Brown LF,Washington CT,et al.Keloid demonstrate high-level epidermal expression of vascular endothelial growth factor.J Am Acad Dermatol.2004,50(6):650-653
[104]姜笃银,徐明达,陈璧,等.瘢痕疙瘩组织血管生长因子及其受体表达的意义.第四军医大学学报.1998,19(4):470-471
[105]李军辉,邢新,欧阳天祥,等.异常瘢痕中血管内皮细胞生长因子和增殖性核抗原的表达.现代康复.2000,4(9):1358-1359
[106]沈锐,利天增,祁少海,等.靶向血管治疗增生性瘢痕的实验研究.中华整形外科杂志.2003,19(4):254-256
1.李荟元,刘建波,兰海.建立增生性瘢痕动物实验模型.第四军医大学学报,1998,19(6):655-657
2.刘流,赵德萍,余梅,等.丹参对瘢痕成纤维细胞生物学行为的影响.昆明医学院学报,2006,(3):41-45
3.雷水生,唐省三,张瑞莲,等.川芎嗪对瘢痕成纤维细胞形态和增殖抑制的影响.齐齐哈尔医学院学报,2003,24(6):606-607
4.陈明春,黄茂芳.积雪草甙和苦参碱对皮肤瘢痕成纤维细胞生长及胶原合成影响的研究.中国中西医结合皮肤性病学杂志,2006,5(1):11～14
5.李万同,罗力生,柳大烈.汉防己甲素对增生性瘢痕成纤维细胞增殖和活力的影响.现代康复,2000,4(1):66-67
6.姚恒,李世荣,刘剑毅.三七总甙对人增生性瘢痕成纤维细胞 TGF-β_1和细胞周期的作用.中国实用美容整形外科杂志,2005,16(4):243-245
7.谢举临,利天增,祁少海,等.积雪草甙对体外培养的成纤维细胞的作用.中山医科大学学报,2001,22(1):41-43,47
8.汤苏阳,黄高升,蔡宝仁.苦参碱对人增生性瘢痕成纤维细胞超微结构的影响.中国美容医学,2001,10(2):100-101
9.任丽虹,郝立君,段国新,等.五倍子、蜈蚣对瘢痕疙瘩成纤维细胞增殖和胶原合成的影响.实用美容整形外科杂志,2003,14(6):324-327
10.刘流,赵德萍,余梅,等.丹参对兔耳瘢痕模型作用的实验研究.华西口腔医学杂志,2006,24(5):476-477
11.刘德伍,李国辉,刘德明,等.粉防己碱对瘢痕成纤维细胞的生物学作用.江西医学院学报,2001,41(3):4-6
12.王芊,曹德君.丹参对培养的人瘢痕成纤维细胞生长和胶原形成的影响.中国临床药学杂志,2002,11(1):46-48
13.左强,张培华,罗少军,等.丹参酮Ⅱ A 对瘢痕成纤维细胞增殖及凋亡的影响.广东医学,2004,25(6):636-637
14.郭海霞,吴延芳.川芎嗪和甘利欣对瘢痕成纤维细胞增殖和Ⅰ、Ⅲ型前胶原基因表达的影响.中国中西医结合皮肤性病学杂志,2002,1(1):27-30
15.刘剑毅,李世荣,纪淑兴,等.三七总甙对人增生性瘢痕成纤维细胞及胶原合成的作用.第三军医大学学报,2003,17(9):1562-1563
16.沈丹蓓,夏隆庆,鞠强,等.五倍子等对体外培养的人皮肤瘢痕组织成纤维细胞生长的影响.中华皮肤科杂志,2002,35(4):299-301
17.沈雁,李叶杨,唐毅,等.鸦胆子粗提物抑制人成纤维细胞的实验研究.广东药学院学报,2001,(17)2:109-111
18.雷晓红,曹志明,黄恩.丹参对增生性瘢痕成纤维细胞胶原合成的影响及其机制研究.中国临床康复,8(32):7231～7233
19.汤苏阳,蔡宝仁,黄高升,等.苦参碱对人增生性瘢痕成纤维细胞周期和 PCNA 表达的影响.现代康复,2001,5(9):48-49
20.商庆新,张涤生,关文祥,等.丹参和川芎嗪对瘢痕成纤维细胞生长的体外抑制实验.中国修复重建外科杂志,1998,12(6):321-323
21.李宇明,李生,李建宁,等.消瘢醑对瘢痕疙瘩成纤维细胞增殖的影响.中国微创外科杂志,2004,4(6):531-532
22.王瑞国,王锦菊,余祥彬,等.积雪草甙对成纤维细胞 DNA 合成与胶原蛋白合成的影响.福建中医学院学报,2001,11(2):41-42
23.商庆新,张涤生,关文祥,等.丹参和川芎嗪对瘢痕成纤维细胞 DNA 含量及细胞周期进程的影响.中国修复重建外科杂志,1998,12(6):325-327
24.曹治东,石崇荣,黄崇本,等.汉防己甲素对增生性瘢痕成纤维细胞增殖的影响.重庆医科大学学报,2005,30(2):203-205
25.张培华,罗少军,梁杰,等.芦荟大黄素对增生性瘢痕成纤维细胞凋亡的量效影响.中国临床康复,2005,9(30):152-154
26.钟晓春.粉防己碱促进增生性瘢痕成纤维细胞凋亡的实验研究.杭州师范学院学报,2005,4(6):426-427
27.雷晓红,曹志明,黄恩.丹参对增生性瘢痕成纤维细胞 Survivin 表达的影响及意义.中国临床康复,2004,8(35):8042-8044
28.姜会庆,哈团柱,韦多,等.丹参素对成纤维细胞生物学作用机制的研究,中华烧伤杂志,2001,17(1):36-38
29.雷晓红,曹志明,黄恩.丹参对增生性瘢痕成纤维细胞生长的影响.中国临床康复,2004,8(29):6440-6441
30.兰海,王臻,张琳西,等.川芎嗪抑制瘢痕成纤维细胞增殖及胶原的合成.第四军医大学学报,1999,20(11):964-965
31.刘德伍,李国辉,刘德明.粉防己碱对瘢痕成纤维细胞活性功能的影响.中华医学美容杂志,2002,8(4):201-204
32.吴志远,罗少军,汤少明,等.丹参酮ⅡA 对兔耳增生性瘢痕组织形成的影响.广东医学院学报,2002,20(4):255,259
33.张涛,荣新洲,杨荣华,等.积雪草甙对增生性瘢痕转化生长因子-β mRNA 及基质金属蛋白酶类表达的影响.南方医科大学学报,2006,26(1):67-70
34.李万同,柳大烈,罗力生.汉防己甲素对成纤维细胞Ⅰ型胶原蛋白合成的影响.实用美容整形外科杂志,2002,13(6):327-329
35.黄辉,李宇明,陈东明,等.消瘢醑对瘢痕疙瘩成纤维细胞Ⅰ、Ⅲ型胶原蛋白的影响.中国微创外科杂志,2003,3(3):249-251
36.李万同,柳大烈,刘晓燕,等.汉防己甲素对增生性瘢痕成纤维细胞基质金属蛋白酶Ⅰ合成的影响.中国临床康复,2005,9(10):106-107
37.王益民.丹参抑制瘢痕形成的机制研究.山西医科大学学报,2001,32(4):302-303
38.潘姝,利天增,李叶扬,等.积雪草甙对增生性瘢痕成纤维细胞增殖与 Smad7蛋白的影响.第三军医大学学报,2005,27(1):49-52
39.刘德伍,李国辉,邹萍,等.粉防己碱对 PDGF、TGF-β诱导瘢痕成纤维细胞增殖与胶原合成的抑制作用.中国药理与临床,2004,20(4):10～11
40.苏毅鹏,匡瑞霞,鲍国春,等.川芎嗪等多种中药制剂对兔耳增生性瘢痕作用的对比研究.齐鲁医学杂志,2004,19(4):322-324
41.陈远征,刘达恩,王润秀,等.防治瘢痕外用复方中药对兔耳增生性瘢痕微血管及血流的影响.中国临床康复,2006,10(7):43-44